A. Cavalli

Markers of microbial translocation during pregnancy: differences among HIV+ women of African and European provenance

Silvia Baroncelli, Clementina Maria Galluzzo, A. Molinari, Maria Franca Pirillo et autres

INTRODUCTION: Microbial translocation (MT) markers are indicators of HIV-related immune activation, but reference values are mostly derived from European or North American populations and could be substantially different in populations living in developing countries. Here we evaluate possible differences in MT markers …

it (code pays fourni par la source)

P.05.13 HIGH PREVALENCE OF FUNCTIONAL CONSTIPATION IN EPILEPTIC PATIENTS

Carola Severi, Marilia Carabotti, Chiara Di Bonaventura, Danilo Badiali et autres

Direct antiviral agents therapy can induce a partial restoration of the antiviral immune functions in patients with chronic hepatitis C virus infection

Amalia Penna, Masaji Mase, Eva Negri, Marco Pesci et autres

Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target

Marina Bolzoni, Martina Chiu, Fabrizio Accardi, Rosanna Vescovini et autres

The importance of glutamine (Gln) metabolism in multiple myeloma (MM) cells and its potential role as a therapeutic target are still unknown, although it has been reported that human myeloma cell lines (HMCLs) are highly sensitive to Gln depletion. In this study, …

gb, it (code pays fourni par la source)

EP-1352: TBI scheme impacted on relapse in acute myeloid leukemia patients after hematopoietic stem cell transplant

Elisa Palazzari, Lucia Amico, Alison Santucci, Alessandra Carotti et autres

Diagnosis of brucellosis and false positive serological reactions: a descent into the "Maelström".

Marialaura Corrente, Erika Grandolfo, A. Cavalli, Attilio Parisi et autres

P187 INNATE ANTIVIRAL RESPONSES IN HBeAg NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (CH-B) UNDER LONG-TERM NUCLEOS(T)IDE ANALOGUE (NUC) TREATMENT: IMPLICATIONS FOR FUTURE IMMUNE THERAPIES

Carolina Boni, Pietro Lampertico, Lavinia Talamona, T. Giuberti et autres

Interindividual and Intra-Individual Variabilities of Darunavir and Ritonavir Plasma Trough Concentrations in Multidrug Experienced HIV Patients Receiving Salvage Regimens

Silvia Baroncelli, Clementina Maria Galluzzo, A. Cavalli, Anna Rita Volpe et autres

BACKGROUND: There is no consensus on darunavir (DRV) target levels in plasma for clinical use, and information about variability in plasma concentrations is limited. AIM: : To investigate the variability in DRV plasma trough concentrations in the clinical setting, evaluating interindividual and …

it, in, cn, de (code pays fourni par la source)

Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study

LE Weimer, Marco Floridia, Raffaella Bucciardini, Silvia Baroncelli et autres

Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study.

Liliana Elena Weimer, Marco Floridia, Raffaella Bucciardini, Silvia Baroncelli et autres

Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV

Paola Fisicaro, Caterina Valdatta, Marco Massari, Elisabetta Loggi et autres

it (code pays fourni par la source)

Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy

Silvia Baroncelli, Clementina Maria Galluzzo, LE Weimer, Maria Franca Pirillo et autres

OBJECTIVES: To evaluate the evolution of HIV-1 coreceptor tropism in proviral DNA of patients during maraviroc-based therapy. METHODS: Fourteen heavily high active antiretroviral therapy (HAART)-treated patients with a CCR5 Trofile profile were monitored over a 24 month period from the start of …

it (code pays fourni par la source)